Is antigen specificity the key to efficient adoptive T‑cell therapy? - Archive ouverte HAL Access content directly
Journal Articles Immunotherapy Year : 2011

Is antigen specificity the key to efficient adoptive T‑cell therapy?

(1) , (2, 1) , (1, 3) , (1, 2)
1
2
3

Abstract

Adoptive transfer of T cells remains a promising approach in melanoma. Initial clinical trials performed with polyclonal tumor-infiltrating lymphocyte gave limited clinical results. Nonetheless, encouraging results have been reported in adjuvant setting (stage III melanoma), and when tumor-infiltrating lymphocytes were associated with lymphodepleting regimens. Specificity of adoptive cell therapy has been achieved with the infusion of antigen specific cytotoxic T-lymphocyte clones, associated with some clinical responses. Antigen specificity can also be obtained by the allogeneic transfer of high-avidity T-cell receptors into autologous T cells. We propose an alternative strategy based on the selection of antigen-specific T cells with magnetic beads coated with HLA-peptide multimers. Future improvements of adoptive melanoma immunotherapy may be achieved by its association with other therapeutic strategies such as targeted therapy against signaling pathways.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-02481934 , version 1 (17-02-2020)

Identifiers

Cite

Nathalie Labarrière, Amir A Khammari, François Lang, Brigitte Dreno. Is antigen specificity the key to efficient adoptive T‑cell therapy?. Immunotherapy, 2011, ⟨10.2217/IMT.11.16⟩. ⟨inserm-02481934⟩
11 View
1 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More